PORT WASHINGTON, N.Y., May 22, 2025 /PRNewswire/ -- EQUASHIELD®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ...
PORT WASHINGTON, N.Y., Sept. 8, 2023 /PRNewswire/ -- EQUASHIELD, a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its ...
PORT WASHINGTON, New York, Dec. 4, 2019 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, has marked its 10-year milestone ...
New PP&P State of Pharmacy Compounding report shows EQUASHIELD® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...
DUBLIN, May 5, 2021 /PRNewswire/ -- The "Closed System Drug Transfer Device Market Share, Size, Trends, Industry Analysis Report, By Type; By Component; By Closing Mechanism; By Technology; By End-Use ...
The deal puts Equashield at a valuation of $300 million Equashield was founded in 2009 Since inception in 1989, Nordic Capital has invested more than 20 billion euros in equity capital in over 125 ...